Renalytix AI Plc (LON: RENX) has announced a partnership with the University of Michigan.
- The partnership is to extend the use of the KidneyIntelX™ platform to an enlarged population of patients with established CKD (Chronic Kidney Disease) or at risk of developing CKD.
- Company’s first phase of the partnership with the University of Michigan, which will study the potential role of uEGF in further enhancing the prognostic performance of the KidneyIntelX platform in identifying patients at highest risk of fast-progressing DKD (Diabetic Kidney Disease) and kidney failure is expected to be completed in 2020.
- On 30th June 2020, at the time of writing, GMT 08:56 AM, RENX shares were trading at GBX 530.00, down by 527.50 points or 0.47% against the previous day closing price.
With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities.
Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?
Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.
We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.